CFTR and cystic fibrosis: Although the female sex-specific, anti-secretory, effect of estrogen on CFTR may have little consequence in healthy airways, it does pose challenges for the efficacy of CFTR modulator therapy in female CF patients for which recent clinical trials show pulmonary function outcomes less effective than in male CF patients [56].